Common-Size Income Statement
Quarterly Data
Based on: 10-K (reporting date: 2026-09-03), 10-Q (reporting date: 2026-05-28), 10-Q (reporting date: 2026-02-26), 10-Q (reporting date: 2025-11-27), 10-K (reporting date: 2025-08-28), 10-Q (reporting date: 2025-05-29), 10-Q (reporting date: 2025-02-27), 10-Q (reporting date: 2024-11-28), 10-K (reporting date: 2024-08-29), 10-Q (reporting date: 2024-05-30), 10-Q (reporting date: 2024-02-29), 10-Q (reporting date: 2023-11-30), 10-K (reporting date: 2023-08-31), 10-Q (reporting date: 2023-06-01), 10-Q (reporting date: 2023-03-02), 10-Q (reporting date: 2022-12-01), 10-K (reporting date: 2022-09-01), 10-Q (reporting date: 2022-06-02), 10-Q (reporting date: 2022-03-03), 10-Q (reporting date: 2021-12-02), 10-K (reporting date: 2021-09-02), 10-Q (reporting date: 2021-06-03), 10-Q (reporting date: 2021-03-04), 10-Q (reporting date: 2020-12-03).
The financial performance exhibits a profound cyclical trajectory, characterized by an initial period of stability, a severe contraction in profitability, and a subsequent phase of aggressive margin expansion. This pattern is most evident in the dramatic fluctuations of the gross margin and operating income relative to total revenue.
- Gross Margin and Cost of Goods Sold
- A significant volatility cycle is observed in the cost structure. Gross margins remained relatively healthy between 26% and 47% from December 2020 through September 2022. However, a sharp deterioration occurred starting in December 2022, with gross margins plummeting to a nadir of -32.66% in March 2023, coinciding with cost of goods sold reaching 132.66% of revenue. A steady recovery began in early 2024, with margins returning to positive territory in February 2024 (18.53%) and accelerating rapidly to reach 86.76% by September 2026. This suggests a transition from a period of severe pricing pressure or inventory write-downs to a period of exceptional pricing power or production efficiency.
- Operating Expense Management
- Research and development (R&D) and selling, general, and administrative (SG&A) expenses showed an inverse relationship with revenue trends. As a percentage of revenue, R&D spending peaked during the downturn in March 2023 at -21.34%, indicating that R&D costs remained relatively fixed despite falling revenues. As revenue recovered and expanded in the later periods, R&D as a percentage of revenue decreased significantly, ending at -3.53% in September 2026. Similarly, SG&A expenses peaked at -6.26% in March 2023 before declining to -1.58% by September 2026, reflecting improved operational leverage as the company scaled.
- Operating and Net Profitability
- Operating income mirrored the volatility of the gross margin, swinging from a peak of 35.71% in September 2021 to a deep deficit of -62.36% in March 2023. The return to profitability was achieved in February 2024 (3.28%) and entered a phase of hyper-growth, reaching an operating margin of 80.68% by September 2026. Net income followed a nearly identical path, recovering from a low of -62.60% in March 2023 to end the period at 69.52% of revenue, demonstrating an extraordinary increase in bottom-line efficiency.
- Non-Operating Items and Taxation
- Interest income as a percentage of revenue peaked during the period of lowest profitability, reaching 3.38% in June 2023, suggesting a higher reliance on cash reserves or higher interest rate environments during the downturn. Tax provisions remained negligible or provided benefits during the loss-making quarters but became a significant drag as profitability surged, with the income tax provision reaching -12.14% of revenue by September 2026, consistent with the return to high taxable earnings.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?